Medical Uses
TORISEL (temsirolimus), from Pfizer, is indicated for the treatment of advanced renal cell carcinoma (RCC).
Temsirolimus is an mTOR (mechanistic target of rapamycin) inhibitor. By inhibiting mTOR, a key regulator of cell growth, proliferation, and angiogenesis, temsirolimus slows tumor growth and helps limit the tumor’s blood supply in advanced kidney cancer.
